And another one bites the dust.WHO advises against the use of Gilead's remdesivir for all hospitalised COVID-19 patientsThe World Health Organization advised against the use of Gilead Sciences’ antiviral drug remdesivir for treating COVID-19 patients, no matter how ill they are, saying that there is no evidence to suggest that the medicine improves survival or reduces the need to put patients on ventilator. Gilead Sciences, the maker of remdesivir, has called the recommendation "disappointing."
Pete
copy of PAA AGM questions and answers, page-104
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.015(8.11%) |
Mkt cap ! $98.34M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 19.0¢ | $66.44K | 346.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 86359 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 107894 | 5 |
View Market Depth
| Last trade - 15.42pm 13/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |